Watercress has grown wild in freshwater streams across Europe and Western/Central Asia since antiquity, valued by ancient Greek and Persian physicians as both a nutritious food and a general health tonic. Its status as one of the most nutrient-dense leafy greens available has made it a subject of particular modern research interest in cancer-prevention biomarker studies.
Watercress's specific active compounds, isothiocyanates similar to those found in other cruciferous vegetables, have driven a body of research examining whether the plant might offer measurable protective effects against cellular damage linked to cancer development.
Watercress has real, published human randomized trial evidence for one specific area: reducing measurable DNA damage. A randomized, single-blind crossover trial in 60 healthy adults (including smokers and non-smokers) found daily watercress consumption over 8 weeks significantly reduced lymphocyte DNA damage and increased blood antioxidant levels, with the effect notably stronger in smokers. This is a genuine, published human clinical trial finding, not merely laboratory research.
The essential caveat, stated directly by the researchers themselves: lymphocyte DNA damage is "only a surrogate marker of whole-body cancer risk" — meaning this trial demonstrates a plausible protective biomarker effect, not that watercress has been shown to actually reduce cancer incidence or improve cancer outcomes in humans. Given genuine human RCT evidence for a real, relevant biomarker, but an honest gap between that biomarker and any demonstrated disease-outcome benefit, "Limited-Moderate" is the accurate, appropriately bounded rating.
Eaten fresh in salads, or lightly cooked in soups; traditionally consumed raw to preserve its peppery, mustard-like flavor and nutrient content.